Download

Free Electronic Option

Note: Many electronic documents posted prior to 2003 are available as chapter PDFs or HTML files linked from the Contents.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback342 pages $25.00 $20.00 20% Web Discount

This report is one of five volumes providing detailed information on the QA Tools, RAND’s comprehensive, clinically based system for assessing quality of care for children and adults. The QA Tools indicators encompass screening, diagnosis, treatment, and follow-up in 46 clinical areas and cover a variety of modes of providing care, including history,physical examination, laboratory study, medication, and other interventions and contacts. Development of each indicator was based on the ratings of a panel of experts in the relevant fields and on a focused review of the scientific literature, which is clearly documented for each clinical condition. This volume focuses on indicators for care of cardiopulmonary conditions. Each chapter summarizes the results of the literature review for a particular condition, provides RAND staff’s recommended indicators based on that review, and notes the level of scientific evidence supporting each indicator along with the relevant citations. In addition, this work details the process by which the expert panel evaluated the indicators and the final disposition of each indicator. Clinical conditions covered in this volume are: Asthma, atrial fibrillation, cerebrovascular disease, chronic obstructive pulmonary disease, cigarette counseling, community-acquired pneumonia, coronary artery disease, heart failure, hyperlipidemia, hypertension, upper respiratory infections. Other RAND Health titles on the QA Tools system focus on indicators for general medicine, oncology and HIV, children and adolescents, and women.

Table of Contents

  • Preface PDF

  • Tables

    Tables and Figures PDF

  • Acknowledgements

    Acknowledgments PDF

  • Introduction PDF

  • Chapter 1

    Asthma PDF

  • Chapter 2

    Atrial Fibrillation PDF

  • Chapter 3

    Cerebrovascular Disease PDF

  • Chapter 4

    Chronic Obstructive Pulmonary Disease PDF

  • Chapter 5

    Cigarette Counseling PDF

  • Chapter 6

    Community-Acquired Pneumonia PDF

  • Chapter 7

    Coronary Artery Disease - Diagnosis and Screening PDF

  • Chapter 8

    Coronary Artery Disease - Prevention and Treatment PDF

  • Chapter 9

    Heart Failure PDF

  • Chapter 10

    Hyperlipidemia PDF

  • Chapter 11

    Hypertension PDF

  • Chapter 12

    Upper Respiratory Infections PDF

  • Appendix A

    Panel Rating Sheets by Condition PDF

  • Appendix B

    Crosswalk Table of Original and Final Indicators PDF

The study was conducted within RAND Health and supported by the Agency for Healthcare Research and Quality.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.